Description: Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. It offers Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. The company was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.
Home Page: www.nyxoah.com
Rue Edouard Belin 12
Mont-Saint-Guibert,
1435
Belgium
Phone:
32 1 022 23 55
Officers
| Name | Title |
|---|---|
| Mr. Robert Taub MBA | Co-Founder & Chairman |
| Mr. Olivier Taelman | CEO & Exec. Director |
| Mr. Loic Moreau | Chief Financial Officer |
| Ms. Dorit Nahari | VP of Operations |
| Mr. Bruno Onkelinx | Chief Technology Officer |
| Mr. Jeremy Feffer | VP of Investor Relations & Corp. Communication |
| Ms. An Moonen | Gen. Counsel |
Exchange: BR
Country: BE
Currency: Euro (€)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 1.0741 |
| Price-to-Sales TTM: | 70.4786 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 105 |